Identification of genes associated with susceptibility to schizophrenia

鉴定与精神分裂症易感性相关的基因

基本信息

  • 批准号:
    06454606
  • 负责人:
  • 金额:
    $ 3.78万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Dopamine D2 receptor variant, D2Cys311, a missense mutation changing serine 311 in the third intracellular loop to cysteine, and wild type, D2Ser311, were expressed stably in Chinese Ovary Cells and dopamine-induced sequestration was examined by measuring the loss of binding of the hydrophilic ligand sulpiride from the cell surface. A D2S (the short form isoform of dopamine D2 receptor) receptor variant containing Cys311 was found to be sequestered to a significantly smaller extent compared to wild-type D2S receptors, though sequestration of D2L (the long form isoform of D2 receptor) receptors was not so apparent as that of D2S receptors and no apparent difference was found between D2Ser311 and D2Sys311 in D2L receptors.5' flanking region of the dopamine D2 receptor gene was examined to search for nucleotide variants. Two common polymorphic sites, A-584G and Ins/DelG-486, were found. Bmax values for spiperone binding in the putamen were not significantly different between postmortem brains with G-584 and those without it. Each allele frequency of A-584G polymorphism was not significantly different between schizophrenics and controls. Bmax values for spiperone binding in the putamen were marginally significantly higher in postmortem brains with the Ins allele (p<0.03) than in those without it. The Ins allele frequency was significantly frequent in schizophrenics whose age of onset younger than 35 than in controls (p<0.008). These results suggest that some variants in the dopamine D2 receptor gene are involved in susceptibility to some types of schizophrenia.
多巴胺D2受体变异体D2Cys 311和野生型D2 Ser 311在中国人卵巢细胞中稳定表达,并通过测量细胞表面亲水性配体舒必利结合的损失来检查多巴胺诱导的螯合作用。D2S发现与野生型D2 S受体相比,含有Cys 311的多巴胺D2受体(多巴胺D2受体的短型同种型)受体变体的螯合程度显著更小,尽管D2 L的螯合(D2受体的长型同种型)在D2 L受体中,D2 Ser 311和D2 Sys 311的5 '侧翼区没有明显差异。检测多巴胺D2受体基因以寻找核苷酸变体。结果发现两个常见的多态性位点A-584 G和Ins/DelG-486,有和无G-584的脑组织壳核螺哌隆结合Bmax值无显著差异,A-584 G多态性各等位基因频率在精神分裂症组和对照组间无显著差异。在死后脑组织中,具有Ins等位基因的壳核螺哌隆结合的Bmax值略高于不具有Ins等位基因的壳核螺哌隆结合的Bmax值(p<0.03),而Ins等位基因频率在发病年龄小于35岁的精神分裂症患者中显著高于对照组(p<0.008)。这些结果表明,多巴胺D2受体基因的某些变异与某些类型的精神分裂症的易感性有关。

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tadao Arinami: "An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P content...." Biological Psychiatry. (in press).
Tadao Arinami:“血管紧张素转换酶基因中的插入/缺失多态性与脑 P 物质含量相关......”生物精神病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masanari Itokawa: "Sequestration of the D2S and D2L dopamine receptor isoforms expressed in Chinese hamster ovary cells" Molecular Pharmacology. (in press).
Masanari Itokawa:“中国仓鼠卵巢细胞中表达的 D2S 和 D2L 多巴胺受体亚型的隔离”分子药理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
有波 忠雄: "D2レセプターの遺伝子解析" 日本神経精神薬理学雑誌. 14. 129-137 (1994)
Tadao Arami:“D2 受体的基因分析”日本神经精神药理学杂志 14. 129-137 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Arinami T,Itokawa M,Enguchi H.Tagaya H,Yano S,Shimizu H,Hamaguchi H,Toru M: "Association of dopamine D2 receptor molecular variant with schizophrenia" Lancet. 343. 703-704 (1994)
Arinami T、Itokawa M、Enguchi H.Tagaya H、Yano S、Shimizu H、Hamaguchi H、Toru M:“多巴胺 D2 受体分子变异与精神分裂症的关联”柳叶刀。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Arinami T,Takekoshi K,Itokawa M,Hamaguchi H,Toru M: "Failure to find associations of the CA repeat polymorphism in the first intron and the Gly-63/Glu-63 polymorphism of the neurotrophin-3 gene with schizophrenia" Psychiatric Genetics. (in press).
Arinami T、Takekoshi K、Itokawa M、Hamaguchi H、Toru M:“未能发现第一个内含子中的 CA 重复多态性和神经营养素 3 基因的 Gly-63/Glu-63 多态性与精神分裂症的关联”精神病遗传学
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAMAGUCHI Hideo其他文献

HAMAGUCHI Hideo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAMAGUCHI Hideo', 18)}}的其他基金

Identification of the susceptive genes for atopic diseases using positional candidate gene approaches.
使用位置候选基因方法鉴定特应性疾病的易感基因。
  • 批准号:
    11470504
  • 财政年份:
    1999
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Autosomal dominant hypercholesterolemia due to mutant apolipoprotein B genes
载脂蛋白 B 基因突变导致常染色体显性高胆固醇血症
  • 批准号:
    03671090
  • 财政年份:
    1991
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Analysis of genes causing autosomal dominant hypercholesterolemia
常染色体显性高胆固醇血症的基因分析
  • 批准号:
    63571084
  • 财政年份:
    1988
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Analysis of Locus for Autosomal Dominant Hyperlipidemia
常染色体显性遗传性高脂血症基因座分析
  • 批准号:
    61571088
  • 财政年份:
    1986
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Association of genetic variation near the dopamine D2 receptor gene and other polymorphisms that modulate dopaminergic and opioid signaling on the weight loss response to naltrexone/bupropion
多巴胺 D2 受体基因附近的遗传变异与调节多巴胺能和阿片类信号传导对纳曲酮/安非他酮减肥反应的其他多态性的关联
  • 批准号:
    10586181
  • 财政年份:
    2023
  • 资助金额:
    $ 3.78万
  • 项目类别:
Dopamine D2 Receptor Mutations and Hyperkinetic Movement Disorders
多巴胺 D2 受体突变和多动性运动障碍
  • 批准号:
    10640977
  • 财政年份:
    2022
  • 资助金额:
    $ 3.78万
  • 项目类别:
Development of dopamine D2 receptor-targeted DARTs
多巴胺 D2 受体靶向 DART 的开发
  • 批准号:
    10376835
  • 财政年份:
    2021
  • 资助金额:
    $ 3.78万
  • 项目类别:
Inhibitory mechanisms of neutrophilic inflammation induced by the activation of dopamine D2 receptor
多巴胺D2受体激活诱导中性粒细胞炎症的抑制机制
  • 批准号:
    21K09920
  • 财政年份:
    2021
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of GPR143 in the regulation of dopamine D2 receptor signaling
GPR143 参与多巴胺 D2 受体信号传导的调节
  • 批准号:
    19K16375
  • 财政年份:
    2019
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of adenosine 2a receptor antagonist on striatal dopamine D2 receptor: a human PET study
腺苷 2a 受体拮抗剂对纹状体多巴胺 D2 受体的影响:人类 PET 研究
  • 批准号:
    19K21217
  • 财政年份:
    2018
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
多巴胺 D2 受体选择性配体的基于结构的药物发现
  • 批准号:
    10212202
  • 财政年份:
    2017
  • 资助金额:
    $ 3.78万
  • 项目类别:
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
多巴胺 D2 受体选择性配体的基于结构的药物发现
  • 批准号:
    9980500
  • 财政年份:
    2017
  • 资助金额:
    $ 3.78万
  • 项目类别:
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
多巴胺 D2 受体选择性配体的基于结构的药物发现
  • 批准号:
    9406684
  • 财政年份:
    2017
  • 资助金额:
    $ 3.78万
  • 项目类别:
Allosteric Targeting Of The Dopamine D2 Receptor: A Novel Approach For The Treatment Of Parkinson’s Disease And Schizophrenia
多巴胺 D2 受体的变构靶向:治疗帕金森病和精神分裂症的新方法
  • 批准号:
    nhmrc : 1098424
  • 财政年份:
    2016
  • 资助金额:
    $ 3.78万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了